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Background: The prevalence of infection with Toxoplasma gondii (T. gondii) in humans has been increasing in
China due to the growing number of cats in the country. Hand, foot and mouth disease (HFMD) is a serious public
health issue in China and still one of the leading causes of child mortality. However, little is known about the
epidemiology of T. gondii infection among HFMD patients.
Methods: A case–control study of 281 HFMD patients from the First People’s Hospital of Pingdingshan in
Pingdingshan city, Henan province, central China, and 222 controls from Pingdingshan city was conducted.
Anti-T. gondii antibodies were serologically detected using the enzyme-linked immunosorbent assay.
Results: We found that the overall anti-T. gondii immunoglobulin G (IgG) antibody prevalence among HFMD
patients was 12.46 %, which was significantly higher than that in clinically healthy children (1.80 %). The
highest T. gondii seroprevalence was detected in critical cases (22.58 %), followed by severe cases (11.50 %),
and the lowest was detected in mild cases (8.33 %).
Conclusion: The present study is the first survey of T. gondii seroprevalence among HFMD patients in China;
12.46 % were defined as seropositive. It is imperative that improved integrated measures are taken to prevent
and control T. gondii infection among HFMD patients.
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Hand, foot and mouth disease (HFMD) is a common
viral illness mainly caused by coxsackievirus A16 (Cox
A16) and enterovirus 71 (EV71) [1, 2] infections.* Correspondence: lsg1963@163.com
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(http://creativecommons.org/publicdomain/zeChildren under five years of age are more susceptible to
HFMD, as over 50 % of children in this age bracket lack
the neutralizing antibodies that protect against EV71
and Cox A16 infections [1, 3, 4].
Symptoms of HFMD include fever, headache and poor
appetite, followed by an intensely sore throat and a rash
with very small blisters on the hands, feet and diaper
area. A small number of children suffer complications
such as myocarditis, pulmonary edema and aseptic men-
ingoencephalitis, which can be fatal [5–7]. Occasionally,
adults can contract HFMD [1, 8].
Since the 1980s, a number of severe HFMD outbreaks
have been documented and HFMD remains a significant
public health challenge, especially in the Asia-Pacific regionis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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HFMD in China in 2008, the incidence of reported cases
has sharply increased, with more than seven million cases
reported, including approximately 2,500 deaths [11]. From
1 January 2008 to 31 December 2013, a total of 400,264
HFMD cases have been reported in the Henan province
alone, including 22,309 severe and 141 fatal cases [11].
According to the guidelines of the National Health
and Family Planning Commission (NHFPC) of the People’s
Republic of China for diagnosis and treatment of HFMD
(2010 edition, http://www.nhfpc.gov.cn/), HFMD cases are
classified as mild, severe or critical. In mild cases, a skin
rash appears on the hands, feet, mouth or buttocks of the
patient, with or without fever. In severe cases, in addition
to the above, patients can experience deflated moods or
lethargy; become easily frightened or delirious; develop
headaches; suffer from vomiting, limb shaking, myoclonus,
nystagmus, ataxia, eye movement disorders, weakness or
acute flaccid paralysis; and/or experience convulsions.
There are also visible signs of meningeal irritation, and ten-
don reflexes are diminished or absent. In critical cases, at
least one of the following has to occur: frequent convul-
sions, coma and brain herniation; dyspnea, cyanosis,
bloody foam sputum, pulmonary rales, etc.; or shock and
other signs of circulatory insufficiency.
Toxoplasma gondii (T. gondii) is a protozoan parasite
that can infect virtually all warm-blooded animals, in-
cluding humans. It has been estimated that one-third of
the world’s population has been infected with this para-
site [14, 15]. The prevalence of infection with T. gondii in
humans has been increasing in China due to the growing
number of cats in the country [16]. Although in immuno-
competent individuals, most T. gondii infections are asymp-
tomatic, the infection can lead to serious diseases among
immunocompromised patients such as HIV-positive and
cancer patients, and transplant recipients [17–19].
Hand, foot and mouth disease is a serious public health
issue in China and still one of the leading causes of child
mortality. Numerous studies have shown that Th1/Th2
and Th17/Treg imbalances exist in HFMD patients [20].
Children with HFMD caused by the EV71 infection can
suffer from functional disorders of cell, humoral and
innate immunity [21]. Any of these functional disorders
can increase the chance of infection with opportunistic
pathogens such as T. gondii [22]. Yet, epidemiological
knowledge about the prevalence of T. gondii infection
among HFMD patients is unavailable in China. The
present study is the first to estimate the prevalence of T.
gondii infection among HFMD patients in China.
Methods
Sample collection
A total of 281 clinically diagnosed HFMD patients (24
mild cases, 226 severe cases and 31 critical cases) fromthe First People’s Hospital of Pingdingshan in Pingding-
shan city, Henan province, central China, were enrolled
in the study from March to April 2014. The HFMD
patients were classified into mild, severe or critical
cases, according to the guidelines of the NHFPC of the
People’s Republic of China for diagnosis and treatment of
HFMD (2010 edition, http://www.nhfpc.gov.cn/). Demo-
graphic data such as gender and age were obtained. Two
hundred and twenty-two control subjects, matched with
HFMD patients by age, gender and residence, were also
included in the study. They were clinically healthy chil-
dren without EV71, CoxA16 or other enterovirus infec-
tions, all from Pingdingshan city.
Samples of approximately 4 ml of venous blood
were taken from each patient and the control subjects
with informed consent. All blood samples were la-
belled individually and cooled using ice packs to
maintain the temperature at 4 °C during transporta-
tion to the laboratory.Serum sample preparation
Blood samples were centrifuged and sera were recovered
and transferred to 1.5 ml Eppendorf Tubes™. The serum
samples were stored at − 80 °C until tested for T. gondii
antibodies.Toxoplasma-IgG assessment
Immunoglobulin G (IgG) antibodies of T. gondii were
detected using a commercially manufactured enzyme-
linked immunosorbent assay (ELISA) kit (Zhuhai S.E.Z.
Haitai Biological Pharmaceuticals Co., Ltd, Zhuhai,
China). The manufacturer’s instructions were followed
to conduct the procedure. In brief, test serum (1:100
dilution) was added to each well in the coated plate and
incubated for 30 minutes at 37 °C. After additional wash-
ing with a washing solution (PBS containing 0.05 %
Tween20, PBST), 50 μL of peroxidase-conjugated anti-
human IgG was added to the wells and incubated at 37 °C
for 30 minutes. This was followed by three washes using
the washing solution. The colour reactions were devel-
oped by adding 50 μL “A” solution (H2O2) and 50 μL “B”
solution (3,3′,5,5′-Tetramethylbenzidine) at 37 °C for
10 minutes, and then the reaction was stopped by adding
50 μL of stopping solution (0.5 ml/L H2SO4). Microplates
were read at an optical density (OD) of 450nm in the
Model 550 microplate ELISA reader (Bio-Rad, Hercules,
CA, USA), and ratios (OD450 nm value of serum sample/
OD450 nm value of negative control) were calculated after
correcting for the OD450 nm value of the blank control
(without serum and peroxidase-conjugated anti-human
IgG). Test serum samples were considered positive when
the ratio was ≥2.1.
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Statistical analysis was performed using the SPSS ver-
sion 20 software for Windows (SPSS Inc., Chicago,
Illinois, USA). The chi-square test was used to per-
form statistical analyses of T. gondii prevalence using
different variables. Differences were considered statis-
tically significant if p < 0.05.Ethical statement
The study was reviewed and approved by the Ethical
Review Committee of the Xinxiang Medical University
(reference no. 2013008). Written informed consent was
obtained from all participants.Results
As shown in Table 1, anti-T. gondii IgG antibodies were
detectable in the sera of 35 HFMD cases (35/281), with
an overall seroprevalence of 12.46 %. For clinically
healthy children, a total of four (1.80 %) of the 222 sam-
ples were positive for anti-T. gondii IgG antibodies. The
seropositive rate of the former was significantly higher
than that of the latter (X2 = 19.681, p <0.001).
In HFMD cases, the seroprevalence of T. gondii in
males was 12.30 % (23/187) and 12.77 % (12/94) in
females. No significant difference between genders was
observed (X2 = 0.012, p = 0.911). The highest seropreva-
lence of T. gondii infection was found among children in
the age group of one to two years (16.09 %, 14/87) and
the lowest was found among children in the age
group of < one year (8.87 %, 11/124). However, the
difference between age groups was not significantly
significant (p >0.05) (see Table 1).
Table 2 shows the clinical diagnosis data of HFMD
patients based on the severity of their disease. The
seroprevalence of T. gondii infection was highest in
critical cases (22.58 %, 7/31), followed by severe cases
(11.50 %, 26/226), and was the lowest in mild casesTable 1 Seroprevalence of Toxoplasma gondii infection in the study
Variable HFMD patients Control subje
No. examined No.of positive Prevalence (%) No. examine
Gender
Male 187 23 12.30 130
Female 94 12 12.77 92
Age (year)
<1 124 11 8.87 64
1 ~ 2 87 14 16.09 56
2 ~ 3 44 6 13.64 52
>3 26 4 15.38 50
Total 281 35 12.46 222(8.33 %, 2/24). However, no statistically significant
differences were observed among the three groups
(X2 = 3.476, p = 0.176).Discussion
Infection with T. gondii in humans is common all
around the world, with prevalence rates varying depend-
ing on the environment, people’s eating habits and age
[23]. The two nation-wide surveys carried out in 1995
and 2004 reported that the prevalence of T. gondii infec-
tion in the Chinese population was around 7 % [24]. In
2010, the infection rate of T. gondii in the Chinese popu-
lation increased to 12.3 % [25].
In the present study, 12.46 % (35/281) of HFMD
patients were seropositive for T. gondii. This is higher
than that reported in HIV-positive patients (3.5–7.7 %)
[26, 27], similar to the general infection rate of T. gondii
(12.3 %) [25], and lower than that observed in female
sterility patients (15.9 %) [28], patients in intensive care
units (18.78 %) [23], psychiatric patients (17.30 %) [29],
cancer patients (35.56 %) and dialysis patients (27.3 %)
[30, 31] in China.
Additionally, the seropositive rate of T. gondii infec-
tion among HFMD patients was significantly higher than
that of clinically healthy children (1.80 %). Children with
HFMD caused by the EV71 infection can suffer from
functional disorders of cell, humoral and innate immun-
ity [20, 21], which can reduce the body’s resistance to
opportunistic pathogens such as T. gondii and predis-
pose them to develop secondary toxoplasmosis. Latent
T. gondii infections could also be activated. However,
whether the prevalence of T. gondii infection can in-
crease the risk of contracting HFMD and affect the dis-
ease outcome of HFMD patients requires further study.
In the present study, female HFMD patients had a
higher prevalence than male patients, although the dif-
ference was not significant (p > 0.05). Gender was thuspopulations in China
cts HFMD patients vs control subjects
d No.of positive Prevalence (%) X2 P-value
4 3.08 8.371 0.004
0 0 12.555 <0.001
0 0 4.527 0.033
0 0 9.989 0.002
0 0 5.415 0.02
4 8.00 0.362 0.548
4 1.80 19.681 <0.001
Table 2 Clinical diagnosis and seroprevalence of T. gondii in
HFMD patients in China
Clinical
classification
Patients with anti-T. gondii antibodies
No.examined No.of positive Prevalence (%)
Mild cases 24 2 8.33a
Severe cases 226 26 11.50a
Critical cases 31 7 22.58a
Total 281 35 12.46
Values bearing a different superscript letter (a) within a column differ
significantly from one another (p < 0.05)
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gondii antibodies (P >0.05), which was consistent with
other reports [32, 33].
Rates of T. gondii infection increased with age in this
study, however, the difference between age groups was
not significantly significant (p >0.05). A hypothesis
would be that the increase is a reflection of increasing
‘exposure years’ as the children get older [32]. The re-
sults provided further evidence for the increased risk of
T. gondii infection with acquisition of age. Seropreva-
lence of T. gondii infection was highest in critical HFMD
cases, followed by severe cases, and the lowest was de-
tected in mild cases, with percentages of CD4+, CD8+ T
and CD16+56+ cells (natural killer cells) continuously
decreasing as the disease worsens [21]. Additionally,
CD4+ and CD8+ T cells and natural killer cells play
important roles in the process of anti-T. gondii infection
[34, 35]. These findings might explain why the probabil-
ity of seroprevalence with T. gondii infection increases
with the severity of the HFMD disease. With respect to
the increased numbers of HFMD patients worldwide,
toxoplasmosis should be considered as potentially asso-
ciated with HFMD in humans.Conclusion
The present study revealed for the first time the sero-
prevalence of T. gondii infection among HFMD patients
in the Henan province, China. Further studies should be
conducted to estimate the prevalence of T. gondii infec-
tion among HFMD patients in other provinces of China,
with increased sample sizes.Additional files
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